Abiopharma

🔍 Tomkiel Melissa M. (Director)

Company: Strata Critical Medical, Inc. (SRTA)

Report Date: 2026-04-23

Detailed Transactions and Holdings:

• Acquired 630,264 shares of Class A common stock, $0.0001 par value per share (Direct)
  Date: 2026-04-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,244,254.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 321,750 shares of Class A common stock, $0.0001 par value per share at $4.92 per share (Direct)
  Date: 2026-04-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,922,504.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
• F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.